These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 15473910

  • 1. Cerebral relapse of metastatic gastrointestinal stromal tumor during treatment with imatinib mesylate: case report.
    Hughes B, Yip D, Goldstein D, Waring P, Beshay V, Chong G.
    BMC Cancer; 2004 Oct 09; 4():74. PubMed ID: 15473910
    [Abstract] [Full Text] [Related]

  • 2. [A case of metastatic gastrointestinal stromal tumor developing a resistance to STI571 (imatinib mesylate)].
    Miyake M, Takeda Y, Hasuike Y, Kashiwazaki M, Mishima H, Ikenaga M, Mano M, Takada Y, Hirota S, Tsujinaka T.
    Gan To Kagaku Ryoho; 2004 Oct 09; 31(11):1791-4. PubMed ID: 15553717
    [Abstract] [Full Text] [Related]

  • 3. [New orientations in the management of advanced, metastatic gastrointestinal stromal tumors (GIST): combination of surgery and systemic therapy with imatinib in a case of primary gastric location].
    Catani M, De Milito R, Simi M.
    Chir Ital; 2005 Oct 09; 57(1):127-33. PubMed ID: 15832750
    [Abstract] [Full Text] [Related]

  • 4. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
    Mearadji A, den Bakker MA, van Geel AN, Eggermont AM, Sleijfer S, Verweij J, de Wilt JH, Verhoef C.
    Anticancer Drugs; 2008 Jul 09; 19(6):607-12. PubMed ID: 18525320
    [Abstract] [Full Text] [Related]

  • 5. [Peritoneal dissemination from gastrointestinal stromal tumor of small intestine responding completely to imatinib mesylate (STI 571)].
    Yamanaka H, Mizushima T, Mikata S, Ito T, Nonaka K, Ide H, Michiura T, Kainuma S, Iwase K.
    Gan To Kagaku Ryoho; 2005 Dec 09; 32(13):2125-8. PubMed ID: 16352942
    [Abstract] [Full Text] [Related]

  • 6. Two cases of complete response after imatinib mesylate treatment of advanced GIST.
    Papaxoinis G, Nikolaou M, Lianos E, Gaglia A, Economopoulos T, Pectasides D.
    Anticancer Res; 2006 Dec 09; 26(6C):4869-72. PubMed ID: 17214353
    [Abstract] [Full Text] [Related]

  • 7. Large duodenal gastrointestinal stromal tumor presenting with acute bleeding managed by a whipple resection. A review of surgical options and the prognostic indicators of outcome.
    Machado NO, Chopra PJ, Al-Haddabi IH, Al-Qadhi H.
    JOP; 2011 Mar 09; 12(2):194-9. PubMed ID: 21386652
    [Abstract] [Full Text] [Related]

  • 8. Rhabdomyosarcomatous differentiation in gastrointestinal stromal tumors after tyrosine kinase inhibitor therapy: a novel form of tumor progression.
    Liegl B, Hornick JL, Antonescu CR, Corless CL, Fletcher CD.
    Am J Surg Pathol; 2009 Feb 09; 33(2):218-26. PubMed ID: 18830121
    [Abstract] [Full Text] [Related]

  • 9. A metastatic case of gastrointestinal stromal tumor (GIST) treated with imatinib mesylate (Glivec(®)) in Mali.
    Diallo DA, Ly M, Diallo G, Dembélé AK, Touré M, Touré BA, Koné A, Sidibé S, Dembelé M, Traore BC.
    Clin Res Hepatol Gastroenterol; 2011 Oct 09; 35(10):675-7. PubMed ID: 21641899
    [Abstract] [Full Text] [Related]

  • 10. [A case of recurrent gastrointestinal stromal tumor with complete response from treatment with reduced dose of imatinib mesylate].
    Toyokawa T, Yamashita Y, Yamamoto A, Shimizu S, Inoue T, Ikehara T, Sakashita K, Kanehara I, Teraoka H, Nishiguchi Y.
    Gan To Kagaku Ryoho; 2012 Nov 09; 39(11):1723-5. PubMed ID: 23152028
    [Abstract] [Full Text] [Related]

  • 11. Imatinib mesylate treatment for advanced gastrointestinal stromal tumor: a pilot study focusing on patients experiencing sole liver metastasis after a prior radical resection.
    Zhu J, Wang Y, Hou M, Li HY, Zhang J.
    Oncology; 2007 Nov 09; 73(5-6):324-7. PubMed ID: 18497504
    [Abstract] [Full Text] [Related]

  • 12. Surgical management in metastatic gastrointestinal stromal tumor (GIST) patients after imatinib mesylate treatment.
    Yeh CN, Chen TW, Tseng JH, Liu YY, Wang SY, Tsai CY, Chiang KC, Hwang TL, Jan YY, Chen MF.
    J Surg Oncol; 2010 Nov 01; 102(6):599-603. PubMed ID: 20976730
    [Abstract] [Full Text] [Related]

  • 13. [Imatinib mesylate alone for refractory advanced gastrointestinal stromal tumor].
    Shen L, Jin ML.
    Zhonghua Zhong Liu Za Zhi; 2004 Nov 01; 26(11):697-9. PubMed ID: 15777512
    [Abstract] [Full Text] [Related]

  • 14. [Successful treatment of huge peritoneal metastasis from duodenal gastrointestinal stromal tumor resistant for imatinib mesylate].
    Sakakura C, Kumano T, Mizuta Y, Yamaoka N, Sagara Y, Hagiwara A, Otsuji E.
    Gan To Kagaku Ryoho; 2007 Nov 01; 34(12):2144-6. PubMed ID: 18219926
    [Abstract] [Full Text] [Related]

  • 15. [Imatinib mesylate in the treatment of advanced gastrointestinal stromal tumors].
    Wan DS, Wu XJ, Pan ZZ, Zhou ZW, Chen G, Li LR, Lu ZH, Ding PR.
    Zhonghua Yi Xue Za Zhi; 2006 Nov 21; 86(43):3064-7. PubMed ID: 17288838
    [Abstract] [Full Text] [Related]

  • 16. [Treatment of metastatic gastrointestinal stromal tumors with Imatinib: report of four cases].
    Garrido S M, Moneada M M, Tapia N G, Méndez O G, Galindo A H, Huete G A, Ibáñez A L, González S, Alvarez Z M.
    Rev Med Chil; 2007 Oct 21; 135(10):1327-32. PubMed ID: 18180842
    [Abstract] [Full Text] [Related]

  • 17. [Hepatic metastasis from gastric GIST radically resected after imatinib mesylate therapy-a case report].
    Kittaka H, Yamada T, Goto K, Ogawa H, Shingai T, Motoori M, Takahashi H, Kishi K, Noura S, Miyashiro I, Ohue M, Ohigashi H, Yano M, Ishikawa O.
    Gan To Kagaku Ryoho; 2011 Nov 21; 38(12):2508-10. PubMed ID: 22202429
    [Abstract] [Full Text] [Related]

  • 18. Retinal neovascularization and hemorrhage associated with the use of imatinib (Gleevec(®)) in a patient being treated for gastrointestinal stromal tumor (GIST).
    Gulati AP, Saif MW.
    Anticancer Res; 2012 Apr 21; 32(4):1375-7. PubMed ID: 22493373
    [Abstract] [Full Text] [Related]

  • 19. [Imatinib in gastrointestinal stromal tumor treatment--results from University Hospital Centre Zagreb].
    Vrbanec D, Petricević B, Majerović M, Stern-Padovan R, Belev B, Skegro M, Herceg D, Plestina S, Dedić-Plavetić N, Jakić-Razumović J.
    Lijec Vjesn; 2006 Apr 21; 128(5-6):161-6. PubMed ID: 16910417
    [Abstract] [Full Text] [Related]

  • 20. Management of gastrointestinal stromal tumors in the imatinib era: selected case studies.
    Benjamin RS, Blanke CD, Blay JY, Bonvalot S, Eisenberg B.
    Oncologist; 2006 Jan 21; 11(1):9-20. PubMed ID: 16401709
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.